Kiernan McCollough
Papers
1
Total Citations
14
H-Index
1
About
Dr. Kiernan McCollough is a leading figure in the field of radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for primary renal cell carcinoma. His major contribution lies in pioneering nephron-sparing robotic radiosurgical approaches, offering a non-invasive alternative for patients with stage I kidney cancer who are either poor surgical candidates or refuse surgery. His landmark 2019 study, which has garnered 14 citations, prospectively evaluated toxicity and efficacy in 21 patients with solitary renal tumors, demonstrating that SBRT can achieve excellent local control while preserving renal function. This work has helped shift the paradigm for early-stage renal cancer treatment, providing a critical option for patients seeking to avoid the morbidity of traditional surgery. Dr. McCollough’s research is particularly impactful for its rigorous, single-institution prospective design, which has informed clinical guidelines and inspired further multi-institutional trials. His dedication to refining non-surgical, organ-sparing therapies continues to shape the future of oncologic care, making him a respected voice in the radiation oncology community.
Research Focus
Key Achievements
Top Papers
- 1